We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

US recommends pausing J&J vaccine distribution over rare blot clots

12 4 4
13.04.2021

WASHINGTON (AP) — The US is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating clots in six women that occurred 6 to 13 days after vaccination. The clots were observed in the sinuses of the brain along with reduced platelet counts — making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”

More than 6.8 million doses of the J&J vaccine have been administered in the US, the vast majority with no or mild side effects.

Get The Times of Israel's Daily Edition by email and never miss our top stories Free Sign Up

US federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow. The other two authorized vaccines, from Moderna and Pfizer, make up the vast share of COVID-19 shots administered in the US and are not affected by the pause. In this March 31, 2021 photo, a nurse fills a syringe with a dose of the Johnson & Johnson’s one-dose COVID-19 vaccine at the Vaxmobile, at the Uniondale Hempstead Senior Center, in Uniondale, New York. (AP Photo/Mary Altaffer, File)

CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also........

© The Times of Israel


Get it on Google Play